Ritonavir was added to long-term bone marrow (BM) culture at a concentration of 5 nm. Culture medium consisted of stem cell medium, supplemented with hydrocortisone succinate with or without retonavir, and was replaced weekly. Colonies were assessed after 5 weeks as described in “Materials and methods” (n = 2).